ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2022

[Efficacy and safety of Camrelizumab and AVD in the first-line treatment of classic Hodgkin's lymphoma].

K Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.